
I've gone from a size 20 to an 8 & lost 8 stone on Mounjaro – I've had hair loss but don't mind, I like my locks thinner
A WOMAN has revealed that thanks to Mounjaro, she has lost eight stone and has dropped from a size 20 to an 8.
But Alexandra, 33, who is from the UK and is currently living in Dubai, expressed that since using weight-loss jabs, she has suffered with hair loss.
3
3
However, the content creator isn't bothered by this, as she claimed she likes her locks thinner.
Posting on social media, the brunette beauty, who previously revealed the very scary impact stopping Mounjaro had on her body, shared a before and after look at how her figure has changed since using the fat jabs.
In just 12 months, Alexandra confirmed that she lost eight stone, as she wrote: 'What a journey the last year has been. 8 stone lost.'
Alexandra confirmed that during April 2024 to April 2025, she was able to totally transform her life, as she recognised: 'Fat and miserable in the UK to living my best life in Dubai.
'I never would have dreamed life could be this good.'
When asked if she experienced hair loss, the young woman confirmed: 'I did at month four, horrible but no issues now and I like my hair a bit thinner.'
Mounjaro, which is known as the King Kong of jabs, is now being prescribed on the NHS in the first anti-obesity rollout of its kind.
It is said to suppress the appetite, making people feel fuller for longer.
Such injections are licensed for patients with type 2 diabetes and to assist those who are clinically obese - with a Body Mass Index of 30 or over.
One jab is administered each week but the duration is dependent on a person's weight.
The drugs can be lawfully supplied only when prescribed by a practitioner - like a doctor, nurse or a pharmacist-independent prescriber.
But many are buying them through online pharmacies with insufficient checks.
And just earlier this month, a fat jab warning was issued after more than 100 UK deaths were linked to weight loss drugs.
Not only this, but the family of a man from Burton upon Trent, Staffs, who died after taking Mounjaro, are now calling for a probe into the jab's "potential to kill".
Social media users react
Alexandra's TikTok clip, which was posted under the username @ alexandraindubai, has clearly left many open-mouthed, as it has quickly racked up 67,500 views, 3,617 likes and 70 comments.
Social media users were stunned by Alexandra's new figure and many raced to the comments to express this.
One person said: 'You look amazing.'
Another added: 'Wow! That's incredible! Well done you!'
Everything you need to know about fat jabs
Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases.
Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK.
Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market.
Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year.
How do they work?
The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight.
They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists.
They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high.
Can I get them?
NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics.
Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure.
GPs generally do not prescribe the drugs for weight loss.
Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk.
Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health.
Are there any risks?
Yes – side effects are common but most are relatively mild.
Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea.
Dr Sarah Jarvis, GP and clinical consultant at patient.info, said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.'
Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia.
Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health.
Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines.
A third commented: 'Amazing! You must feel brilliant.'
In response, Alexandra wrote back and shared: 'I feel much better that's for sure!! Thank you!'
Meanwhile, someone else questioned: 'Is it worth it?'
To this, Alexandra confirmed: 'Best thing I've ever done!'
The reality of Mounjaro
But despite Alexandra's weight loss success, last year it was revealed that Scots nurse Susan McGowan, 58, died after taking low-dose injections of Mounjaro over a fortnight.
A probe also found that nearly 400 people have gone to hospital after taking weight loss drugs.
Whilst Alexandra dealt with hair loss, the common side effects include nausea, vomiting and diarrhoea, which can lead to severe dehydration.
What are the other side effects of weight loss jabs?
Like any medication, weight loss jabs can have side effects.
Common side effects of injections such as Ozempic include:
Nausea: This is the most commonly reported side effect, especially when first starting the medication. It often decreases over time as your body adjusts.
Vomiting: Can occur, often in conjunction with nausea.
Diarrhea: Some people experience gastrointestinal upset.
Constipation: Some individuals may also experience constipation.
Stomach pain or discomfort: Some people may experience abdominal pain or discomfort.
Reduced appetite: This is often a desired effect for people using Ozempic for weight loss.
Indigestion: Can cause a feeling of bloating or discomfort after eating.
Serious side effects can also include:
Pancreatitis: In rare cases, Ozempic may increase the risk of inflammation of the pancreas, known as pancreatitis, which can cause severe stomach pain, nausea, and vomiting.
Kidney problems: There have been reports of kidney issues, including kidney failure, though this is uncommon.
Thyroid tumors: There's a potential increased risk of thyroid cancer, although this risk is based on animal studies. It is not confirmed in humans, but people with a history of thyroid cancer should avoid Ozempic.
Vision problems: Rapid changes in blood sugar levels may affect vision, and some people have reported blurry vision when taking Ozempic.
Hypoglycemia (low blood sugar): Especially if used with other medications like sulfonylureas or insulin.
And if that wasn't bad enough, doctors say they have also seen 'life-threatening complications', including seizures, bowel obstruction and inflammation of the pancreas.
Model Lottie Moss, 27, even said she had a seizure after taking high doses of Ozempic.
The makers of Mounjaro, Lilly UK, said patient safety is its 'top priority'.
Lilly UK stressed: 'Regulatory agencies conduct extensive independent assessments of the benefits and risks of every new medicine and Lilly is committed to continually monitoring, evaluating, and reporting safety data.
'If anyone is experiencing side effects when taking any Lilly medicine, they should talk to their doctor or other healthcare professional.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
an hour ago
- The Independent
This 10-year plan may be the last chance to save the NHS
The 10-year plan for the National Health Service that Sir Keir Starmer is expected to publish in the next few days is likely to be a somewhat incoherent document. From the advance publicity, it would seem to have a lot of disconnected ideas in it, some good, some not so good and some irrelevant. The government hopes that weight-loss drugs will offer the hope of a big advance against obesity-related illnesses – but this comes after new figures raised concerns about their safety. If large language models can speed up the development of new pharmaceuticals, so much the better. But we remain sceptical about whether supermarkets ought to be recruited into policing their customers' calorie intakes. What will decide the success or failure of the NHS over the next decade, however, will be the design of the structural reforms to the service. Wes Streeting, the health and social care secretary, has made a good start in two respects. He has welcomed private-sector providers to help deliver NHS services free at the point of need, and he has taken an axe to the central bureaucracy of NHS England. The test for the 10-year plan will be the extent to which it brings in further changes to incentives throughout the NHS so that it becomes responsive to patients. Sir Jim Mackey, the new chief executive of the NHS, says many of the right things. 'It feels like we've built mechanisms to keep the public away because it's an inconvenience,' he says in his first interview since taking up the post three months ago. He says of the current NHS: 'It takes forever. It costs a fortune. We need to 'de-layer it' because it's expensive, it slows decision-making down, it de-powers people who need to make decisions.' The sentiment is right, but again, some of his ideas seem better than others. We are not convinced that using patient satisfaction surveys to decide how much money NHS trusts receive is going to work. The evidence of reform under the last Labour government was that the mere existence of competition from private-sector providers had a dramatic effect on the performance of NHS units. Already, there are the very early signs that the extra resources put into the NHS are bearing fruit, less than 12 months after the change of government. Luke Tryl, the opinion pollster for More in Common, reported on BBC's Newsnight on Friday that people in focus groups are starting to report positive experiences of the NHS for the first time since the pandemic. 'If there is a bright spot for the government, it's the NHS,' he said. One of the biggest challenges for Sir Jim and Mr Streeting, however, is more political than structural. They have to send the starkest message to doctors: please do not go on strike; take responsibility; show leadership; it is up to you to make the NHS work, because if it cannot be turned round this time, then it probably is the end of this model of healthcare. Sir Jim appears to understand this. He says that his 'big worry' is that if the NHS cannot deliver a service that is better at listening to patients – the particular example he gave was maternity care – 'we'll lose the population; if we lose the population, we've lost the NHS; for me, it's straightforward: the two things are completely dependent on each other.' He is absolutely right. Universal healthcare free at the point of need is a noble idea, but it desperately needs Labour's reforms to work if it is to survive.


The Sun
2 hours ago
- The Sun
From mushrooms to guarana – three products to help you prevent dehydration
AS I've signed up to this summer's Manchester Half marathon I'm going to be doing some (sweaty) training, so prioritising hydration is crucial. When we sweat we don't just lose water but vital minerals such as sodium, potassium and calcium too. Maintaining their balance is vital to prevent dehydration and electrolytes are key. I've put three – which also have added extras – to the test. PROTEIN ELLE Macpherson's company WelleCo has released The HydroProtein Elixir. In addition to 15g of pea protein per serving it has electrolytes (sodium, potassium and magnesium) for hydration, and a beauty blend (vitamin C, hyaluronic acid, niacin and biotin) for glowing skin. It's also got vitamin B5 for energy. The blackcurrant and pomegranate flavour had a refreshing sharpness. I love that this is a great mixture of ingredients and just 63 calories per serving. The HydroProtein Elixir, £35, MUSHROOMS FOURFIVE is a new firm founded by professional rugby players George Kruis and Dom Day. Their Hydro Hydration Energy and Focus drink contains five key electrolytes calcium, potassium, chloride, magnesium and sodium as well as lion's mane mushrooms and ginseng which help with energy, focus and mental clarity. This also has eight B vitamins and 76mg of caffeine which is about the same as a cup of instant coffee but also contains an amino acid called L-theanine which stops you feeling jittery after caffeine. The Hydro Energy and Focus powder is Red Berry flavour – which is delightful, not too sharp or sweet – and comes as a single, 7-pack or 30-pack sachets (5.5g) from about £1.10 a sachet. From Holland & Barrett or Nell McAndrew's marathon guide GUARANA MUCH more than just another energy drink, Phizz Daily Energy, features a specialised hydration formula and a high-strength, scientifically formulated B-vitamin complex. B-vitamins are important in helping your body convert food into energy, supporting everything from brain function to helping to reduce tiredness and fatigue. Plus, with a blend of caffeine and guarana extract, it provides 75mg of caffeine per tablet. Guarana berries contain three times more caffeine than coffee but it's released slowly, meaning Phizz Daily Energy provides sustained energy over time. They cost £7.99 for a tube of x 20 tablets. For more information, see


The Sun
2 hours ago
- The Sun
I had a stroke two years ago and STILL can't swallow – help!
OUR resident specialist and NHS GP, Dr Zoe Williams, shares her expert advice. Today, Dr Zoe helps a reader who is suffering from total dysphagia and wants to know which treatments are available. 2 Q) FOLLOWING a stroke two years ago at the age of 69, I have total dysphagia and have been peg tube fed since. Everything else is back to normal except the ability to swallow but despite doing all the exercises, given by the Speech and Language Therapy team, nothing has worked. Neuromuscular electrical stimulation therapy is private and expensive. Is there any other treatment available? A) Dysphagia is the inability to swallow, which is why you have been fed via a tube into the stomach. I'm sorry to hear that you haven't seen improvement despite support from SALT. NMES aims to retrain the nerves and muscles, and SALT exercises increase effectiveness. But it lacks sufficient robust evidence at the moment to be rolled out. However, it can be used as part of clinical trials or audits. A newer NHS-supported treatment, pharyngeal electrical stimulation, targets the throat's pharynx region. It aims to 'rewire' nerve pathways. Clinical trials (eg, the PHADER study) show it improves swallowing safety and reduces aspiration risk in stroke patients. The NHS is also currently investigating transcranial magnetic stimulation (TMS) aimed to reactivate swallowing centres in the brain. Other therapies include Botox if muscle stiffness is an issue and surgery to dilate the oesophagus. Do request a multidisciplinary reassessment (neurologist and SALT) to explore your options. And do ask about NHS trials.